11/14/2024
11:29 AM | Burning Rock Biotech (Subject)
Kynam Capital Management, LP (Filed by)
| Form SC 13G/A | |
09/27/2024
8:15 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024
6:27 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024
12:59 PM | Burning Rock Biotech (Filer)
| Form 424B3 | |
09/06/2024
5:16 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2024
5:06 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024
5:04 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024
5:08 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024
5:05 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
5:06 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
5:17 AM | Burning Rock Biotech (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/26/2024
7:30 AM | Burning Rock Biotech (Subject)
| Form F-6 POS | |
04/26/2024
7:30 AM | Burning Rock Biotech (Subject)
Citibank,N.A./ADR (Filed by)
Citibank,N.A./ADR (Filed by)
| Form F-6 POS | |
04/26/2024
5:06 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024
4:25 PM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
11:45 AM | Burning Rock Biotech (Subject)
Kynam Capital Management, LP (Filed by)
| Form SC 13G/A | |
02/13/2024
4:23 PM | Burning Rock Biotech (Subject)
LAV Biosciences Fund V, L.P. (Filed by)
| Form SC 13G | |
02/09/2024
7:01 PM | Burning Rock Biotech (Subject)
GIC Private Ltd (Filed by)
| Form SC 13G/A | |
01/10/2024
3:08 PM | Burning Rock Biotech (Subject)
Kynam Capital Management, LP (Filed by)
| Form SC 13G | |
01/04/2024
5:01 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023
5:09 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/30/2023
5:08 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2023
5:08 AM | Burning Rock Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
